GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Senomyx Inc (NAS:SNMX) » Definitions » 5-Year EBITDA Growth Rate

Senomyx (Senomyx) 5-Year EBITDA Growth Rate : 0.00% (As of Jun. 2018)


View and export this data going back to 2004. Start your Free Trial

What is Senomyx 5-Year EBITDA Growth Rate?

Senomyx's EBITDA per Share for the three months ended in Jun. 2018 was $-0.07.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of Senomyx's 5-Year EBITDA Growth Rate

For the Specialty Chemicals subindustry, Senomyx's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Senomyx's 5-Year EBITDA Growth Rate Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Senomyx's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Senomyx's 5-Year EBITDA Growth Rate falls into.



Senomyx 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Senomyx  (NAS:SNMX) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Senomyx 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Senomyx's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Senomyx (Senomyx) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Senomyx Inc manufactures and sells a variety of favors for the packaged food, beverage, and ingredient supply industries. The firm's product portfolio has three primary categories: sweetmyx, savorymyx, and bittermyx. Sweetmyx ingredients are used to increase a product's sweet taste while reducing sugar usage. Savorymyx ingredients are used to increase a product's savory flavors as well as reduce MSG, nucleotides, and sodium in food and beverage products. Bittermyx ingredients are used to reduce a product's bitter taste.
Executives
Christopher J Twomey director 4767 NEXUS CENTRE DRIVE, SAN DIEGO CA 92121
John Poyhonen director, officer: President & CEO 11088 N TORREY PINES RD, C/O SENOMYX INC, LA JOLLA CA 92037
Stephen A Block director INTERNATIONAL FLAVORS & FRAGRANCES INC., 521 WEST 57TH ST, NEW YORK NY 10019
Mary Ann Gray director 201 W 70TH ST, SUITE 23K, NEW YORK NY 10023
Richard R Mashaal 10 percent owner C/O RIMA SENVEST MANAGEMENT, L.L.C., 540 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Senvest Management, Llc 10 percent owner 540 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Michael E Herman director CERNER CORP 2800 ROCKCREEK PARKWAY KANSAS CITY MO 64117-2551
David B Berger officer: Sr. V.P. Gen. Counsel & Sec. 11045 ROSELLE STREET, SAN DIEGO CA 92121
Dennis F Obrien director SENOMYX INC, 11099 NORTH TORREY PINES ROAD, LA JOLLA CA 92037
Harry J Leonhardt officer: SVP, Gen.Counsel & Corp. Sec. C/O HALOZYME THERAPEUTICS, INC., 11388 SORRENTO VALLEY BLVD., SAN DIEGO CA 92121
Mark Leschly director RHO CAPITAL PARTNERS, INC., 152 W 57TH ST 23RD FL, NEW YORK NY 10019
David Schnell director 525 UNIVERSITY AVE, SUITE 1350, PALO ALTO CA 94301
Timothy J Wollaeger director
Beeley Nigel R A officer: VP Discovery ARENA PHARMACEUTICALS INC 6166 NANCY RIDER DRIVER SAN DIEGO CA 92121
Rho Management Trust I 10 percent owner C/O RHO CAPITAL PARTNERS, INC., 152 W. 57TH STREET, 23RD FLOOR, NEW YORK NY 10019